Oligometastatic breast cancer to parotid gland with complete response.

Breast disease Pub Date : 2023-01-01 DOI:10.3233/BD-210049
Veruska Peron, Mariana Miyasaki Piovesana, Eni Martins Medeiros, Bruno André Di Ricco, Vitor Teixeira Liutti
{"title":"Oligometastatic breast cancer to parotid gland with complete response.","authors":"Veruska Peron,&nbsp;Mariana Miyasaki Piovesana,&nbsp;Eni Martins Medeiros,&nbsp;Bruno André Di Ricco,&nbsp;Vitor Teixeira Liutti","doi":"10.3233/BD-210049","DOIUrl":null,"url":null,"abstract":"<p><p>Breast cancer metastatic to parotid gland is a very rare condition which tend to confer poor prognosis and challenging approaches. Oligometastatic breast cancer is usually defined as advanced breast cancer with less or equal than 5 metastatic lesions. We report a case of oligometastatic HER-2 breast cancer to parotid gland and lymph nodes which presented with left hemifacial swelling with erythema and enlargement of cervical and axillary lymph nodes. After 6 cycles of Docetaxel plus Trastuzumab the patient had complete response that was complemented with posterior surgical removal of primary tumor followed by radiotherapy directed to plastron, left supraclavicular and cervical drainage. The patient is still on Trastuzumab therapy and is free of disease in the last two years. We discuss the presentation and approach of a patient with metastatic breast cancer to parotid gland in the oligometastatic scenario.</p>","PeriodicalId":9224,"journal":{"name":"Breast disease","volume":"42 1","pages":"67-71"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/BD-210049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Breast cancer metastatic to parotid gland is a very rare condition which tend to confer poor prognosis and challenging approaches. Oligometastatic breast cancer is usually defined as advanced breast cancer with less or equal than 5 metastatic lesions. We report a case of oligometastatic HER-2 breast cancer to parotid gland and lymph nodes which presented with left hemifacial swelling with erythema and enlargement of cervical and axillary lymph nodes. After 6 cycles of Docetaxel plus Trastuzumab the patient had complete response that was complemented with posterior surgical removal of primary tumor followed by radiotherapy directed to plastron, left supraclavicular and cervical drainage. The patient is still on Trastuzumab therapy and is free of disease in the last two years. We discuss the presentation and approach of a patient with metastatic breast cancer to parotid gland in the oligometastatic scenario.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
腮腺少转移性乳腺癌完全缓解。
乳腺癌转移到腮腺是一种非常罕见的疾病,往往会导致预后不良和具有挑战性的方法。少转移性乳腺癌通常定义为转移灶少于或等于5个的晚期乳腺癌。我们报告一例少转移HER-2乳腺癌到腮腺和淋巴结,表现为左半面肿胀,红斑,颈部和腋窝淋巴结肿大。在6个周期的多西他赛加曲妥珠单抗治疗后,患者获得完全缓解,并辅以后路手术切除原发肿瘤,随后进行针对板、左锁骨上和颈椎引流的放疗。该患者仍在接受曲妥珠单抗治疗,并且在过去两年中没有疾病。我们讨论了转移性乳腺癌患者在腮腺少转移的情况下的表现和方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Breast disease
Breast disease Medicine-Oncology
CiteScore
1.80
自引率
0.00%
发文量
59
期刊介绍: The recent expansion of work in the field of breast cancer inevitably will hasten discoveries that will have impact on patient outcome. The breadth of this research that spans basic science, clinical medicine, epidemiology, and public policy poses difficulties for investigators. Not only is it necessary to be facile in comprehending ideas from many disciplines, but also important to understand the public implications of these discoveries. Breast Disease publishes review issues devoted to an in-depth analysis of the scientific and public implications of recent research on a specific problem in breast cancer. Thus, the reviews will not only discuss recent discoveries but will also reflect on their impact in breast cancer research or clinical management.
期刊最新文献
Sentinel node in breast cancer as an indicator of quality in medical care: Evaluation of statistics in Colombia. Telangiectasias induced by combination tucatinib and ado-trastuzumab emtansine in a patient with metastatic breast cancer. Clinicopathological analysis of 38 male patients diagnosed with breast cancer. Impact of the COVID-19 pandemic on breast cancer pathological stage at diagnosis in Tunisian patients. Use of axillary ultrasound to guide breast cancer management in the genomic assay era.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1